Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels.

Trial Profile

Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2012

At a glance

  • Drugs Rosuvastatin (Primary) ; Fenofibrate; Omega 3 fatty acids
  • Indications Dyslipidaemias
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Sep 2012 New trial record
    • 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top